FDA warns of foot, leg amputations with J&J diabetes drug - Reuters

Reuters

FDA warns of foot, leg amputations with J&J diabetes drug Reuters Johnson & Johnson (JNJ.N) is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday. Final results from two clinical trials showed leg and foot ... FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug LabelRegulatory Focus Diabetes Drug Invokana Must Warn Patients About Increased Risk Of Foot, Leg AmputationConsumerist FDA Cites Increased Amputation Risk With Diabetes Drug CanagliflozinP&T Community The Pharma Letter (registration) -PerfScience -GoozerNation -FDA all 40 news articles »